Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: A pilot study

Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):640-2. doi: 10.4103/0378-6323.168341.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Chemotherapy, Adjuvant
  • Child
  • Dexamethasone / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Pemphigus / drug therapy*
  • Pentoxifylline / administration & dosage*
  • Phosphodiesterase Inhibitors / administration & dosage*
  • Pilot Projects
  • Remission Induction / methods
  • Severity of Illness Index
  • Sulfasalazine / administration & dosage*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Phosphodiesterase Inhibitors
  • Tumor Necrosis Factor-alpha
  • Sulfasalazine
  • Dexamethasone
  • Pentoxifylline